No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance

por Cyll, Karolina, Löffeler, Sven, Carlsen, Birgitte, Skogstad, Karin, Plathan, May Lisbeth, Landquist, Martin, Haug, Erik Skaaheim
Publicado 2022

Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer

por Ersvær, Elin, Kildal, Wanja, Vlatkovic, Ljiljana, Cyll, Karolina, Pradhan, Manohar, Kleppe, Andreas, Hveem, Tarjei S., Askautrud, Hanne A., Novelli, Marco, Wæhre, Håkon, Liestøl, Knut, Danielsen, Håvard E.
Publicado 2019

Tumour heterogeneity poses a significant challenge to cancer biomarker research

por Cyll, Karolina, Ersvær, Elin, Vlatkovic, Ljiljana, Pradhan, Manohar, Kildal, Wanja, Avranden Kjær, Marte, Kleppe, Andreas, Hveem, Tarjei S, Carlsen, Birgitte, Gill, Silje, Löffeler, Sven, Haug, Erik Skaaheim, Wæhre, Håkon, Sooriakumaran, Prasanna, Danielsen, Håvard E
Publicado 2017

PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer

por Cyll, Karolina, Kleppe, Andreas, Kalsnes, Joakim, Vlatkovic, Ljiljana, Pradhan, Manohar, Kildal, Wanja, Tobin, Kari Anne R., Reine, Trine M., Wæhre, Håkon, Brennhovd, Bjørn, Askautrud, Hanne A., Skaaheim Haug, Erik, Hveem, Tarjei S., Danielsen, Håvard E.
Publicado 2021